Financial Ratios Centene Corporation

Stocks

CNC

US15135B1017

Managed Healthcare

Market Closed - NYSE Other stock markets 01:30:02 13/06/2026 am IST			After hours 05:30:00 am
65.19 ^USD	+2.60%		65.20	+0.02%

12/06	Centene Insider Sold Shares Worth $5,164,000, According to a Recent SEC Filing	MT
10/06	Encompass Housing announced that it has received funding from HealthNet Limited, Centene Corporation	CI

dc7bb92e84d6d8d75b4.kqfctaKtrDwzMiuW6T1q5RzbMtKs0hm5O_yXiC3xbks._dKl7-ziwgVBWhPk3HEsqCuqWOXqvUjbCIrfwEGEKRrj5e3a5JzudlF2fg

Published financial data: CENTENE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Premiums and Annuity Revenues	11TCr	13TCr	14TCr	14TCr	17TCr
Total Interest And Dividend Income	42Cr	52Cr	127.2Cr	164Cr	157Cr
Gain (Loss) on Sale of Investments, Total (Rev)	-23Cr	-	-7.5Cr	-	-
Other Revenues, Total	566.4Cr	834.8Cr	445.9Cr	320.2Cr	302.5Cr
Total Revenues	12TCr	14TCr	14TCr	15TCr	18TCr
Policy Benefits	9.86TCr	11TCr	12TCr	13TCr	16TCr
Depreciation & Amortization - (IS) - (Collected)	-	61Cr	58Cr	55Cr	59Cr
Amortization of Goodwill and Intangible Assets - (IS)	77Cr	82Cr	72Cr	69Cr	68Cr
Selling General & Admin Expenses, Total	994.1Cr	1.14TCr	1.24TCr	1.23TCr	1.29TCr
Other Operating Expenses	518.2Cr	729.4Cr	388.6Cr	296.9Cr	301.2Cr
Total Operating Expenses	11TCr	13TCr	14TCr	14TCr	17TCr
Operating Income	368.1Cr	437.9Cr	481.2Cr	492.3Cr	128.6Cr
Interest Expense, Total	-66Cr	-66Cr	-72Cr	-70Cr	-68Cr
Income (Loss) on Equity Invest.	-	-	-	-	-
EBT, Excl. Unusual Items	301.6Cr	371.4Cr	408.7Cr	422.1Cr	61Cr
Restructuring Charges	-5.4Cr	-164.2Cr	-18Cr	-1.3Cr	-2.4Cr
Total Merger & Related Restructuring Charges	-16Cr	-20Cr	-6.9Cr	-8.2Cr	-40L
Impairment of Goodwill	-	-	-	-	-672.3Cr
Gain (Loss) on Sale of Assets	8.8Cr	30Cr	-25Cr	6.1Cr	-51Cr
Asset Writedown	-	-23Cr	-	-1.3Cr	-7.5Cr
Legal Settlements	-126.4Cr	-60L	-	-	-
Other Unusual Items	18Cr	3Cr	1.5Cr	8.3Cr	10L
EBT, Incl. Unusual Items	181.3Cr	196.2Cr	359.8Cr	425.7Cr	-672.8Cr
Income Tax Expense	48Cr	76Cr	90Cr	96Cr	-5.1Cr
Earnings From Continuing Operations	133.6Cr	120.2Cr	269.9Cr	329.4Cr	-667.7Cr
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	133.6Cr	120.2Cr	269.9Cr	329.4Cr	-667.7Cr
Minority Interest	1.1Cr	-	30L	1.1Cr	30L
Net Income - (IS)	134.7Cr	120.2Cr	270.2Cr	330.5Cr	-667.4Cr
Net Income to Common Incl Extra Items	134.7Cr	120.2Cr	270.2Cr	330.5Cr	-667.4Cr
Net Income to Common Excl. Extra Items	134.7Cr	120.2Cr	270.2Cr	330.5Cr	-667.4Cr
Per Share Items
Net EPS - Basic	2.31	2.09	4.97	6.33	-13.53
Basic EPS - Continuing Operations	2.31	2.09	4.97	6.33	-13.53
Basic Weighted Average Shares Outstanding	58Cr	58Cr	54Cr	52Cr	49Cr
Net EPS - Diluted	2.28	2.07	4.95	6.31	-13.53
Diluted EPS - Continuing Operations	2.28	2.07	4.95	6.31	-13.53
Diluted Weighted Average Shares Outstanding	59Cr	58Cr	55Cr	52Cr	49Cr
Normalized Basic EPS	3.25	4.04	4.71	5.08	0.78
Normalized Diluted EPS	3.21	3.99	4.69	5.06	0.78
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	515.7Cr	593.2Cr	610.5Cr	616.4Cr	256.1Cr
EBITA	445.1Cr	519.6Cr	553Cr	561.5Cr	197.1Cr
EBIT	368.1Cr	437.9Cr	481.2Cr	492.3Cr	128.6Cr
EBITDAR	554.7Cr	636.1Cr	645.4Cr	627.2Cr	266Cr
Total Revenues (As Reported)	13TCr	14TCr	15TCr	16TCr	19TCr
Effective Tax Rate - (Ratio)	26.31	38.74	24.99	22.62	0.76
Current Domestic Taxes	62Cr	140.5Cr	96Cr	94Cr	80L
Current Foreign Taxes	70L	40L	10L	-	-
Total Current Taxes	63Cr	140.9Cr	97Cr	94Cr	80L
Deferred Domestic Taxes	-	-	-	1.5Cr	-5.9Cr
Deferred Foreign Taxes	-	-	-	80L	-
Total Deferred Taxes	-15Cr	-65Cr	-6.7Cr	2.3Cr	-5.9Cr
Normalized Net Income	189.6Cr	232.12Cr	255.74Cr	264.91Cr	38Cr
Interest on Long-Term Debt	66Cr	66Cr	72Cr	70Cr	68Cr
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Net Rental Expense, Total	39Cr	43Cr	35Cr	11Cr	9.9Cr
Imputed Operating Lease Interest Expense	10Cr	10Cr	10Cr	3.17Cr	2.86Cr
Imputed Operating Lease Depreciation	29Cr	33Cr	25Cr	7.63Cr	7.04Cr
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	20Cr	23Cr	22Cr	21Cr	20Cr
Total Stock-Based Compensation	20Cr	23Cr	22Cr	21Cr	20Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Total Other Investments	1.56TCr	1.7TCr	1.87TCr	2.01TCr	1.95TCr
Total investments	1.56TCr	1.7TCr	1.87TCr	2.01TCr	1.95TCr
Cash And Equivalents	1.31TCr	1.21TCr	1.72TCr	1.41TCr	1.79TCr
Reinsurance Recoverable - (IS)	2.3Cr	2.6Cr	2.6Cr	6.5Cr	7.6Cr
Other Receivables - (Insurance Template)	1.23TCr	1.34TCr	1.57TCr	1.98TCr	1.82TCr
Gross Property Plant And Equipment	885.7Cr	705.2Cr	481.5Cr	522.9Cr	458.6Cr
Accumulated Depreciation	-190Cr	-206.6Cr	-240Cr	-280.3Cr	-223.2Cr
Net Property Plant And Equipment	695.7Cr	498.6Cr	241.5Cr	242.6Cr	235.4Cr
Goodwill	1.98TCr	1.88TCr	1.76TCr	1.76TCr	1.08TCr
Other Intangibles, Total	782.4Cr	691.1Cr	610.1Cr	540.9Cr	453Cr
Other Current Assets, Total	150.6Cr	232.9Cr	541.9Cr	142.3Cr	176.5Cr
Other Long-Term Assets, Total	128.3Cr	134.9Cr	152.5Cr	162.4Cr	162.3Cr
Total Assets	7.84TCr	7.69TCr	8.46TCr	8.24TCr	7.67TCr
Liabilities
Accounts Payable, Total	828.9Cr	934.5Cr	1.63TCr	1.3TCr	1.33TCr
Insurance And Annuity Liabilities	232.8Cr	163.4Cr	146.2Cr	200.8Cr	159.2Cr
Unpaid Claims	1.42TCr	1.67TCr	1.8TCr	1.83TCr	2.05TCr
Unearned Premiums	43Cr	48Cr	72Cr	66Cr	74Cr
Current Portion of Long-Term Debt	27Cr	8.2Cr	12Cr	11Cr	5Cr
Current Portion of Leases	20Cr	18Cr	17Cr	16Cr	15Cr
Long-Term Debt	1.81TCr	1.77TCr	1.77TCr	1.84TCr	1.74TCr
Long-Term Leases	411.2Cr	338.6Cr	89Cr	74Cr	62Cr
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	-	-	-	30Cr
Deferred Tax Liability Non-Current	140.7Cr	62Cr	64Cr	68Cr	83Cr
Other Non Current Liabilities	199.1Cr	248.3Cr	273.8Cr	182.9Cr	119.6Cr
Total Liabilities	5.14TCr	5.26TCr	5.87TCr	5.59TCr	5.67TCr
Common Stock, Total	10L	10L	10L	10L	10L
Additional Paid In Capital	1.97TCr	2.01TCr	2.03TCr	2.06TCr	2.08TCr
Retained Earnings	813.9Cr	934.1Cr	1.2TCr	1.53TCr	867.4Cr
Treasury Stock	-109.4Cr	-421.3Cr	-585.6Cr	-899.7Cr	-944.1Cr
Comprehensive Income and Other	7.7Cr	-113.2Cr	-65Cr	-50Cr	-5.8Cr
Total Common Equity	2.68TCr	2.41TCr	2.58TCr	2.64TCr	2TCr
Minority Interest	23Cr	18Cr	12Cr	10Cr	10Cr
Total Equity	2.7TCr	2.42TCr	2.6TCr	2.65TCr	2.01TCr
Total Liabilities And Equity	7.84TCr	7.69TCr	8.46TCr	8.24TCr	7.67TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	58Cr	55Cr	53Cr	50Cr	49Cr
ECS Total Common Shares Outstanding	58Cr	55Cr	53Cr	50Cr	49Cr
Book Value / Share	46	43.68	48.35	53.26	40.57
Tangible Book Value	-80Cr	-166.6Cr	218.1Cr	344.3Cr	458.8Cr
Tangible Book Value Per Share	-1.37	-3.02	4.08	6.94	9.33
Total Debt	2.27TCr	2.13TCr	1.89TCr	1.94TCr	1.82TCr
Net Debt	954.3Cr	925.9Cr	168.4Cr	536.6Cr	27Cr
Debt Equivalent Oper. Leases	312Cr	343.2Cr	279.2Cr	86Cr	79Cr
Minority Interest, Total (Incl. Fin. Div)	23Cr	18Cr	12Cr	10Cr	10Cr
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	25Cr	18Cr	16Cr	16Cr	14Cr
Buildings, Total	111.6Cr	66Cr	53Cr	52Cr	49Cr
Machinery, Total	137Cr	97Cr	85Cr	87Cr	67Cr
Full Time Employees	72.5T	74.3T	67.7T	60.5T	61.1T

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	134.7Cr	120.2Cr	270.2Cr	330.5Cr	-667.4Cr
Depreciation, Depletion & Amortization	71Cr	74Cr	58Cr	55Cr	59Cr
Amortization of Goodwill and Intangible Assets - (CF)	77Cr	82Cr	72Cr	69Cr	68Cr
Total Depreciation, Depletion & Amortization	147.6Cr	155.3Cr	129.3Cr	124.1Cr	127.5Cr
(Gain) Loss On Sale of Asset - (CF)	-8.8Cr	-9.3Cr	28Cr	-12Cr	51Cr
(Gain) Loss on Sale of Investments - (CF)	23Cr	-	-	-	-
Total Asset Writedown	-	22Cr	-	1.3Cr	679.8Cr
Restructuring Activities	-	164.2Cr	9.7Cr	-	-
Stock-Based Compensation (CF)	20Cr	23Cr	22Cr	21Cr	20Cr
Change in Accounts Receivable	-245.3Cr	-162.7Cr	-238Cr	-433.3Cr	148Cr
Change in Accounts Payable	114.1Cr	42Cr	339.8Cr	-53Cr	-66Cr
Change in Unearned Revenues	-11Cr	3.1Cr	24Cr	-5.4Cr	8Cr
Change in insurance Reserves / Liabilities	180.2Cr	239.7Cr	126.1Cr	37Cr	233.6Cr
Change in Other Net Operating Assets (Collected)	100Cr	97Cr	86Cr	3.2Cr	-20Cr
Other Operating Activities	-34Cr	-69Cr	9.1Cr	1.8Cr	-6.4Cr
Cash from Operations	420.5Cr	626.1Cr	805.3Cr	15Cr	508.8Cr
Capital Expenditure	-91Cr	-100.4Cr	-80Cr	-64Cr	-77Cr
Cash Acquisitions	-53Cr	-146Cr	-	-	-
Divestitures	6.8Cr	247.7Cr	71Cr	99Cr	-
Investment in Marketable and Equity Securities, Total	-194.2Cr	-293.4Cr	-109.9Cr	-139.8Cr	123.9Cr
Other Investing Activities, Total	1.9Cr	-	-	-	-
Cash from Investing	-329.9Cr	-292.1Cr	-119.1Cr	-105.2Cr	47Cr
Long-Term Debt Issued, Total	926.7Cr	36Cr	233.5Cr	130Cr	75Cr
Total Debt Issued	926.7Cr	36Cr	233.5Cr	130Cr	75Cr
Long-Term Debt Repaid, Total	-743.4Cr	-149Cr	-231.6Cr	-62Cr	-189.5Cr
Total Debt Repaid	-743.4Cr	-149Cr	-231.6Cr	-62Cr	-189.5Cr
Issuance of Common Stock	-	7Cr	4.4Cr	4.6Cr	3.7Cr
Repurchase of Common Stock	-30Cr	-309.6Cr	-163.3Cr	-312.4Cr	-48Cr
Other Financing Activities, Total	-17Cr	-4.1Cr	-8.8Cr	-60L	-3.8Cr
Cash from Financing	136.2Cr	-419.7Cr	-165.8Cr	-240.6Cr	-162.1Cr
Foreign Exchange Rate Adjustments	-1.1Cr	-1.1Cr	-3.2Cr	80L	-
Miscellaneous Cash Flow Adjustments	-	-1.6Cr	-5Cr	-	-14Cr
Net Change in Cash	225.7Cr	-88Cr	512.2Cr	-329.6Cr	380.1Cr
Supplemental Items
Cash Interest Paid	66Cr	66Cr	69Cr	69Cr	65Cr
Cash Income Tax Paid (Refund)	68Cr	122.2Cr	88Cr	100.2Cr	45Cr
Net Debt Issued / Repaid	183.3Cr	-113Cr	1.9Cr	68Cr	-114.5Cr
Levered Free Cash Flow	387.8Cr	333.72Cr	598.24Cr	64Cr	505.3Cr
Unlevered Free Cash Flow	429.36Cr	375.29Cr	643.55Cr	107.69Cr	547.68Cr
Change In Net Working Capital	-122.4Cr	-23Cr	-271.8Cr	280.9Cr	-396.1Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.13	3.53	3.72	3.68	1.01
Return on Total Capital	4.9	5.75	6.65	6.78	1.91
Return On Equity %	5.04	4.69	10.75	12.56	-28.68
Return on Common Equity	5.12	4.73	10.83	12.65	-28.79
Margin Analysis
Gross Profit Margin %	16.56	17.99	15.85	14.57	10.47
SG&A Margin	8.41	8.36	8.78	8.36	7.31
EBITDA Margin %	4.36	4.36	4.32	4.19	1.45
EBITA Margin %	3.77	3.82	3.91	3.82	1.12
EBIT Margin %	3.11	3.22	3.41	3.35	0.73
Income From Continuing Operations Margin %	1.13	0.88	1.91	2.24	-3.79
Net Income Margin %	1.14	0.88	1.91	2.25	-3.79
Net Avail. For Common Margin %	1.14	0.88	1.91	2.25	-3.79
Normalized Net Income Margin	1.6	1.71	1.81	1.8	0.22
Levered Free Cash Flow Margin	3.28	2.45	4.23	0.43	2.87
Unlevered Free Cash Flow Margin	3.63	2.76	4.55	0.73	3.11
Asset Turnover
Asset Turnover	1.61	1.75	1.75	1.76	2.21
Fixed Assets Turnover	21.4	22.77	38.18	60.79	73.7
Receivables Turnover (Average Receivables)	10.3	10.03	9.52	8.19	9.19
Short Term Liquidity
Current Ratio	1.11	1.06	1.11	1.11	1.1
Quick Ratio	1.04	0.97	0.96	1.06	1.05
Operating Cash Flow to Current Liabilities	0.16	0.22	0.22	0	0.14
Days Sales Outstanding (Average Receivables)	35.43	36.4	38.33	44.66	39.72
Average Days Payable Outstanding	84.44	86.05	97.38	100.5	79.61
Long Term Solvency
Total Debt/Equity	83.86	88.02	72.73	73.29	90.56
Total Debt / Total Capital	45.61	46.81	42.11	42.29	47.52
LT Debt/Equity	82.12	86.94	71.62	72.28	89.58
Long-Term Debt / Total Capital	44.66	46.24	41.46	41.71	47.01
Total Liabilities / Total Assets	65.52	68.47	69.33	67.85	73.87
EBIT / Interest Expense	5.54	6.58	6.64	7.01	1.9
EBITDA / Interest Expense	8.34	9.57	8.9	8.93	3.92
(EBITDA - Capex) / Interest Expense	6.97	8.06	7.8	8.02	2.79
Total Debt / EBITDA	4.09	3.35	2.92	3.1	6.83
Net Debt / EBITDA	1.72	1.46	0.26	0.86	0.1
Total Debt / (EBITDA - Capex)	4.89	3.98	3.34	3.45	9.59
Net Debt / (EBITDA - Capex)	2.06	1.73	0.3	0.95	0.14
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.44	15.14	3.89	4.07	19.71
Gross Profit, 1 Yr. Growth %	9.28	25.41	-8.47	-4.72	-13.94
EBITDA, 1 Yr. Growth %	-3.95	16.43	5.1	-0.68	-58.45
EBITA, 1 Yr. Growth %	-7.83	18.39	6.43	-0.28	-64.9
EBIT, 1 Yr. Growth %	-10.44	21	9.89	0.2	-73.88
Earnings From Cont. Operations, 1 Yr. Growth %	-25.53	-10.03	124.54	22.05	-302.7
Net Income, 1 Yr. Growth %	-25.5	-10.76	124.79	22.32	-301.94
Normalized Net Income, 1 Yr. Growth %	-10.89	24.98	10.17	1.09	-85.54
Diluted EPS Before Extra, 1 Yr. Growth %	-26.92	-9.21	139.13	27.47	-314.49
Net Property, Plant and Equip., 1 Yr. Growth %	70.31	-28.33	-51.56	0.46	-2.97
Accounts Receivable, 1 Yr. Growth %	26.28	8.44	17.04	26.9	-8.24
Total Assets, 1 Yr. Growth %	14.05	-1.92	10.11	-2.59	-6.91
Common Equity, 1 Yr. Growth %	3.97	-10.22	7.41	2.21	-24.45
Tangible Book Value, 1 Yr. Growth %	-36.86	108.25	-230.91	57.86	33.26
Cash From Operations, 1 Yr. Growth %	-23.59	48.89	28.62	-98.09	3.2T
Capital Expenditures, 1 Yr. Growth %	4.72	10.33	-20.42	-19.4	19.1
Levered Free Cash Flow, 1 Yr. Growth %	-44.54	-13.08	86.12	-89.44	691.85
Unlevered Free Cash Flow, 1 Yr. Growth %	-42.35	-11.8	77.29	-83.43	408.58
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	29.19	14.2	9.16	4.02	11.62
Gross Profit, 2 Yr. CAGR %	28.01	16.54	5.9	-6.4	-9.45
EBITDA, 2 Yr. CAGR %	26.49	4.11	6.2	3.01	-35.76
EBITA, 2 Yr. CAGR %	25.23	2.63	6.8	3.95	-40.84
EBIT, 2 Yr. CAGR %	19.45	1.94	8.63	6.03	-48.84
Earnings From Cont. Operations, 2 Yr. CAGR %	1.03	-18.15	42.13	65.54	57.29
Net Income, 2 Yr. CAGR %	0.98	-18.46	41.63	65.82	57.16
Normalized Net Income, 2 Yr. CAGR %	17.77	2.89	9.21	6.83	-61.77
Diluted EPS Before Extra, 2 Yr. CAGR %	-14.79	-18.55	47.34	74.59	65.35
Net Property, Plant and Equip., 2 Yr. CAGR %	58.14	10.48	-41.08	-30.25	-1.27
Accounts Receivable, 2 Yr. CAGR %	40.06	17.02	12.67	21.78	7.91
Total Assets, 2 Yr. CAGR %	38.27	5.76	3.92	3.56	-4.78
Common Equity, 2 Yr. CAGR %	46.11	-3.39	-1.8	4.78	-12.13
Tangible Book Value, 2 Yr. CAGR %	-53.02	14.67	65.11	43.76	45.04
Cash From Operations, 2 Yr. CAGR %	68.39	6.66	38.39	-84.32	-20.51
Capital Expenditures, 2 Yr. CAGR %	11.65	7.49	-6.3	-19.91	-2.02
Levered Free Cash Flow, 2 Yr. CAGR %	144.07	-31.24	22.52	-55.44	-8.58
Unlevered Free Cash Flow, 2 Yr. CAGR %	117.4	-29.32	20.93	-45.53	-8.2
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	27.75	24.3	10.66	7.46	9.01
Gross Profit, 3 Yr. CAGR %	22.57	27	7.53	2.39	-8.98
EBITDA, 3 Yr. CAGR %	25.21	22.55	3.71	4.43	-23.89
EBITA, 3 Yr. CAGR %	23.85	22.34	3.88	5.02	-27.61
EBIT, 3 Yr. CAGR %	19.97	19.28	4.52	6.48	-33.53
Earnings From Cont. Operations, 3 Yr. CAGR %	14.33	-2.8	14.58	35.09	77.1
Net Income, 3 Yr. CAGR %	14.39	-3.1	14.33	34.88	77.08
Normalized Net Income, 3 Yr. CAGR %	19.04	19.3	5.26	7.3	-45.15
Diluted EPS Before Extra, 3 Yr. CAGR %	0.29	-12.97	16.63	40.4	86.99
Net Property, Plant and Equip., 3 Yr. CAGR %	59.76	21.47	-16.07	-29.61	-22.13
Accounts Receivable, 3 Yr. CAGR %	33.59	28.61	17.03	17.17	10.81
Total Assets, 3 Yr. CAGR %	36.38	23.31	7.19	1.7	-0.05
Common Equity, 3 Yr. CAGR %	34.89	24.22	0.09	-0.48	-6.04
Tangible Book Value, 3 Yr. CAGR %	-21.65	-22.83	19.85	62.66	40.17
Cash From Operations, 3 Yr. CAGR %	50.48	61.62	13.53	-66.79	-6.68
Capital Expenditures, 3 Yr. CAGR %	10.47	11.21	-2.76	-10.89	-8.58
Levered Free Cash Flow, 3 Yr. CAGR %	32.61	72.43	-5.36	-45.7	16.28
Unlevered Free Cash Flow, 3 Yr. CAGR %	31.75	60.45	-5.03	-37.45	14.69
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	25.68	24.31	20.04	15.75	11.05
Gross Profit, 5 Yr. CAGR %	22.63	25.19	16.07	12.41	0.48
EBITDA, 5 Yr. CAGR %	22.25	26.57	18.37	13.85	-14.09
EBITA, 5 Yr. CAGR %	20.42	26.23	18.74	14.62	-16.76
EBIT, 5 Yr. CAGR %	17.97	24.48	17.68	13.79	-21.13
Earnings From Cont. Operations, 5 Yr. CAGR %	18.95	8.27	24.73	20.27	30.06
Net Income, 5 Yr. CAGR %	19.1	7.74	24.59	20.13	29.85
Normalized Net Income, 5 Yr. CAGR %	16.8	24.49	17.87	14.15	-29.46
Diluted EPS Before Extra, 5 Yr. CAGR %	5.92	-2.42	16.98	14.98	34.11
Net Property, Plant and Equip., 5 Yr. CAGR %	54.24	35.19	7.2	-2.7	-10.44
Accounts Receivable, 5 Yr. CAGR %	30.64	31.3	24.79	25.84	13.26
Total Assets, 5 Yr. CAGR %	31.15	28.6	22.33	15	2.23
Common Equity, 5 Yr. CAGR %	35.37	28.56	18.81	16.04	-4.99
Tangible Book Value, 5 Yr. CAGR %	17.19	18.83	5.57	-1.02	29.35
Cash From Operations, 5 Yr. CAGR %	17.83	33.28	45.52	-36.43	-1.56
Capital Expenditures, 5 Yr. CAGR %	24.36	18.93	3.43	-2.48	-2.47
Levered Free Cash Flow, 5 Yr. CAGR %	2.69	19.96	29.18	-0.4	-6.46
Unlevered Free Cash Flow, 5 Yr. CAGR %	3.98	20.09	27.94	3.46	-6.13